Dave Elich

Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy.

Raymond James & Associates, Inc. (RJA) is a registered broker-dealer headquartered in St. Petersburg, Florida. The firm was founded in 1962 and is a subsidiary of Raymond James Financial, Inc. (NYSE: RJF), a diversified holding company. RJA offers a full array of capital markets services, strategic advice and planning for institutional investors.

Arthrosurface, Inc. engage sin the design and distribution of orthopedic devices for joint preservation, restoration, and resurfacing. It offers HemiCAP system that can be use to treat a variety of joint conditions caused by trauma, injury, and disease. The company was founded by Steven W. Ek, Andrea Patisteas, and Steven J. Tallarida in 2002 and is headquartered in Franklin, MA.

American Biophysics Corp. researches and manufactures biting insect abatement traps for consumer, commercial, and government applications. The company customers include Home Depot, Ace Hardware, Frontgate, and TruServ Corp. Its traps are marketed under the names Pro, Liberty, and Defender. American Biophysics was founded in 1991 and is headquartered in North Kingstown, RI.

Olympus Endo Technology America Inc. manufactures medical devices. It offers GI Endoscopy Devices and Dexterity. The company was founded by Steve J. Tallarida, Robert E. Ailinger and James J. Frassica in 2005 and is headquartered in West Bridgewater, MA.

Saphena Medical, Inc. engages in the innovation and design of medical products. It offer Venapax an endoscopic vessel harvesting technology provides endoscopic vein harvesting solutions. The company was founded by Michael J. Glennon on March 6, 2014 and is headquartered in West Bridgewater, MA.

Founded in 1898, Northeastern University is a private research university located in the heart of Boston. Northeastern teaches worldwide experiential learning, urban engagement, and interdisciplinary research that meets global and societal needs. The University offers a range of undergraduate and graduate programs leading to degrees through the doctorate in nine colleges and schools.

Piper Sandler & Co. operates as an investment company, which engages in the provision of securities brokerage and investment banking services. The company is headquartered in Minneapolis, MN.

Cardiosolutions, Inc. develops and manufactures medical devices. It focuses on a novel percutaneous alternative to open heart surgery to solve the problem of mitral regurgitation. The firm offers Dexterity Steerable Introducer, a multi-use tool that enables physicians to access regions of the cardiac anatomy, which are difficult to reach, including the left side of the heart; and Percu – Pro System for reducing the degree of mitral regurgitation in patients with either functional or degenerative valve disease. The company was founded by Steven J. Tallarida in 2006 and is headquartered in West Bridgewater, MA.

Founded in 2009 by Michael Benoit, Makaira Venture Partners LLC is a venture capital firm located in Stoughton, Massachusetts

Theromics, Inc. is a medical device technology company that is developing a next-generation thermal accelerant technology for soft tissue ablation procedures and combination therapy. The company is based in West Bridgewater, MA. The company's proprietary heatsync™ gel is based on a protein naturally found in the body and may increase cost-efficiencies and improve outcomes through more focused and patient-centric delivery. The company will first focus on tumor ablations and then expand into additional applications, including pain and abnormal uterine bleeding. Longer-term, Theromics plans to apply its thermal technology for use as an oncolytic intratumoral drug/immunotherapy delivery platform with the potential to enhance efficacy and improve safety profiles of currently approved medicines. The company was founded by Damian E. Dupuy, William Keun Chan Park. The CEO is Ron Murphy.